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Abstract
Aim/hypothesis Studies have suggested a link between
insulin resistance and mitochondrial dysfunction in skeletal
muscles. Our primary aim was to investigate the effect of
aerobic training on mitochondrial respiration and mitochon-
drial reactive oxygen species (ROS) release in skeletal muscle
of obese participants with and without type 2 diabetes.
Methods Type 2 diabetic men (n=13) and control (n=14)
participants matched for age, BMI and physical activity
completed 10 weeks of aerobic training. Pre- and post-
training muscle biopsies were obtained before a euglycaemic–
hyperinsulinaemic clamp and used for measurement of
respiratory function and ROS release in isolated mitochondria.
Results Training significantly increased insulin sensitivity,
maximal oxygen consumption and muscle mitochondrial
respiration with no difference between groups. When
expressed in relation to a marker of mitochondrial density
(intrinsic mitochondrial respiration), training resulted in
increased mitochondrial ADP-stimulated respiration (with
NADH-generating substrates) and decreased respiration
without ADP. Intrinsic mitochondrial respiration was not
different between groups despite lower insulin sensitivity in
type 2 diabetic participants. Mitochondrial ROS release
tended to be higher in participants with type 2 diabetes.
Conclusions/interpretation Aerobic training improves mus-
cle respiration and intrinsic mitochondrial respiration in
untrained obese participants with and without type 2 diabetes.
These adaptations demonstrate an increased metabolic fitness,
but do not seem to be directly related to training-induced
changes in insulin sensitivity.
Keywords Exercise . Gene expression . Insulin sensitivity .
Mitochondrial respiration . Reactive oxygen species .
Type 2 diabetes . UCP3
Abbreviations
CS Citrate synthase
CSmito CS activity in the mitochondrial rich solutions
CSmuscle CS activity per g muscle wet weight
ETC Electron chain flux
MHC Myosin heavy chain
RCI Respiratory control index
Rd Rate of glucose disposal
ROS Reactive oxygen species
ROSanti Mitochondrial ROS release in the presence of
antimycin A
ROSrot Mitochondrial ROS release in the presence of
rotenone
State3 ADP-stimulated respiration
State4 Respiration without ADP
U Unit
UCP3 Uncoupling protein isotype 3
V

O2peak Maximal oxygen consumption
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Introduction
Type 2 diabetes and obesity are characterised by skeletal
muscle insulin resistance. Insulin resistance precedes the
development of type 2 diabetes and is seen in non-diabetic
first-degree relatives of patients with type 2 diabetes [1].
Despite intense research, the mechanisms underlying
insulin resistance are not completely understood.
A decade ago Kelley and Mandarino suggested that
insulin resistance in skeletal muscles is caused by mito-
chondrial dysfunction [2]. Since then several studies have
investigated this hypothesis, but so far results have been
ambiguous. When mitochondrial activity was determined
per muscle weight (i.e. muscle oxidative capacity), studies
have either shown no differences [3–5] or a lower [6–12]
mitochondrial activity in insulin-resistant participants.
Studies that have related mitochondrial activity to markers
of mitochondrial volume (intrinsic mitochondrial activity)
have either shown a lower [6, 12, 13] or no difference [9–
11, 14, 15] in mitochondrial activity in insulin-resistant
participants. Thus, reduced insulin sensitivity in insulin-
resistant participants is not consistently related to low
mitochondrial activity.
Recently, it was suggested that beside the potential link
between mitochondrial activity and insulin sensitivity, the
mitochondrial production of reactive oxygen species (ROS)
may also play an essential role in determining skeletal
muscle insulin sensitivity. In cultured cells there is
experimental evidence that ROS have an inhibitory effect
on insulin signalling [16, 17]. Human studies have shown
that obesity and high-fat diet increase mitochondrial
hydrogen peroxide release [18]. Furthermore, a recent study
showed that mitochondrial ROS release was higher in
muscle of patients with type 2 diabetes than in obese
controls, but similar to that observed in lean control
participants [19]. Interestingly, studies have also shown
that a transient physiological increase in ROS may be
essential for a training-induced increase in insulin sensitivity
in type 2 diabetes patients [20] and for protection against
high-fat diet-induced insulin resistance in rodents [21]. Both
these studies [20, 21] suggest that ROS have a beneficial
effect when increased ROS is transient, but are harmful when
the increased concentration is sustained, as seen in response
to chronic hyperglycaemia and dyslipidaemia.
As the major site for cellular ROS production, the
mitochondrion [22] is especially prone to oxidative
damage. The higher mitochondrial ROS release in type 2
diabetes patients [19] may explain the lower intrinsic
mitochondrial activity seen in some studies [6, 12, 13]. It
is, however, possible that mitochondrial ROS release is
influenced by the level of physical fitness [23], which was
not assessed in the previous studies [19]. Thus, it remains to
be established whether mitochondrial ROS production
differs between type 2 diabetes and control participants
who are matched for physical fitness.
It is well known that physical training increases skeletal
muscle insulin sensitivity in type 2 diabetes patients [24].
The mechanism might be related to improved muscle
oxidative capacity [25]. A recent study showed that
physical training improves in vivo mitochondrial function
concomitantly with increased insulin sensitivity in type 2
diabetes patients and control participants [26]. As suggested
by the authors, the improved in vivo mitochondrial function
may be due to increased mitochondrial content and/or
increased functionality per mitochondrion (intrinsic) [26].
These results are in agreement with another study showing
that changes in plasma glucose concentration and HbA1c,
induced by increased physical activity and weight-loss,
were significantly associated with increased mitochondrial
content [27]. Interestingly, it has been suggested that
insulin-resistant participants may have a lower response to
physical training [28]. Recently it was shown that the
response to acute exercise in terms of expression and
protein content of genes coding for mitochondrial biogen-
esis was lower in insulin-resistant non-diabetic participants
than in lean control participants [29]. However, it remains
to be investigated whether the response to physical training
in genes coding for mitochondrial biogenesis is lower in
insulin-resistant participants. It also remains to be assessed
whether physical training alters intrinsic mitochondrial
function in type 2 diabetes patients and control participants.
The purpose of the present study was to investigate the
effect of training on mitochondrial ROS release, mitochon-
drial respiration (both intrinsic and per tissue weight) and
markers of mitochondrial biogenesis in skeletal muscle of
obese type 2 diabetes patients and obese non-diabetic
control participants. We also sought to examine the relation
of training to concomitant changes in insulin sensitivity. We
hypothesised that type 2 diabetes patients (vs obese
controls) would have higher mitochondrial ROS release,
but lower intrinsic mitochondrial respiration, and that these
abnormalities would be improved after endurance training.
Methods
Participants We studied 13 obese type 2 diabetes patients
and 14 obese control participants. Control participants had
normal glucose tolerance (by 120 min OGTT with 75 g
carbohydrate) and no family history of type 2 diabetes.
Type 2 diabetes patients and control participants were
matched for age (45–65 years), sex (all men) and obesity
(BMI>27 kg/m2). Type 2 diabetes patients were treated
with diet alone (n=1) or diet in combination with
sulfonylurea (n=5) or metformin (n=11). The patients were
all negative for GAD65 antibody and had no signs of
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diabetic retinopathy, neuropathy, nephropathy or macro-
vascular complications. All participants had normal results
on blood tests screening for hepatic and renal function. All
participants gave written informed consent and the study
was approved by the local Ethics Committee of Funen and
Vejle County, Denmark. It was performed in accordance
with the Declaration of Helsinki.
All participants completed the pre-training tests (see
below), except one control participant who was unable to
complete the euglycaemic–hyperinsulinaemic clamp test.
Three participants did not complete the post-training test
due to complete interruption of the training programme
(one person per group) or due to unwillingness to repeat the
clamp test (one control). Despite dropouts, all participants
who completed the pre-training tests were included in the
data analysis to increase statistical power for the compar-
ison of mitochondrial ROS release between type 2 diabetes
and control participants.
Training programme Participants underwent 10 weeks of
aerobic training as described previously [30]. Briefly,
training consisted of 10 weeks of cycling on stationary
bikes. Training was partly supervised (two times per week)
and partly done at home (two to three times per week).
Training sessions ranged from 20 to 35 min per session and
were performed four to five times per week at an average
exercise intensity of ∼65% of maximal oxygen consump-
tion V

O2peak
 
. Participants used heart rate monitors (Polar
Vantage; Polar Electro, Kempele, Finland) during all
sessions. Data recorded by the heart rate monitors were
used to verify training intensity and training volume.
Participants were instructed not to make any dietary
changes throughout training programme.
Test protocols Before and after the 10-week training,
participants underwent an exercise test to determine V

O2peak
and a euglycaemic–hyperinsulinaemic clamp, combined with
muscle biopsies as described previously [30]. Briefly, the
euglycaemic–hyperinsulinaemic clamp was performed be-
fore and after the 10 week training programme, ∼48 h after
the last exercise bout. In patients with type 2 diabetes,
medication was withdrawn 1 week prior to the clamp studies
and then resumed. Participants underwent a 2 h basal tracer
equilibration period followed by 3 h of insulin infusion at
80 mU min−1 m−2 after a 12 h overnight fast. Plasma glucose
was allowed to decline to ∼5.5 mmol/l in diabetic partic-
ipants before glucose infusion was initiated. The insulin-
stimulated rate of glucose disposal (Rd) was calculated as the
average amount of glucose (mg min−1 [kg fat-free-mass]−1)
needed to maintain euglycaemia (∼5.5 mmol/l) during the
last 20 min of the clamp.
Muscle biopsies from vastus lateralis muscle were
obtained on the day of the clamp test, but before insulin
infusion, using a modified Bergström needle with suction
under local anaesthesia (10 ml lidocaine 2%). The major
part of the biopsy was used for isolation of mitochondria as
described previously [31]. The remaining part was rapidly
frozen in liquid nitrogen and stored at −80°C for later
determination of uncoupling protein isotype 3 (UCP3)
protein content, enzyme activity, fibre-type distribution
and measures of gene expression.
Respiratory activity of isolated mitochondria The intrinsic
mitochondrial respiratory function (nmol O2 min
−1 [U of
citrate synthase (CS) activity]−1) and respiration per kg wet
weight (mmol O2 min
−1 [kg wet weight]−1) was determined
by measuring oxygen consumption (DW1 Oxygraph;
Hansatech Instruments, King’s Lynn, UK) in isolated
mitochondria at 25°C. The following two protocols were
used (Fig. 1) with substrates being added successively:
& Protocol 1: (1) ADP-stimulated respiration (State3)
(0.3 mmol/l ADP) and respiration without ADP (State4)
(non-coupled respiration) with pyruvate (5 mmol/l) and
L-malate (2 mmol/l) (State3PYRUVATE, State4PYRUVATE);
(2) State3 respiration after further addition of glutamate
(4 mmol/l) (State3PYRUVATE+GLUTAMATE); and (3) max-
imal respiration through permeabilised mitochondria
after addition of cytochrome c (2 µmol/l), alamethicin
(6 µg/ml) and NADH as direct substrate to complex I
(0.4 mmol/l) (electron transport chain flux [ETC]max).
& Protocol 2: (1) State3 and State4 with palmitoyl-L-
carnitine (10 µmol/l) and L-malate (2 mmol/l)
(State3PALMITOYL-L-CARNITINE and State4PALMITOYL-L-
CARNITINE); (2) State3 respiration after further addition of
succinate (6 mmol/l) (State3PALMITOYL-L-CARNITINE+
SUCCINATE); and (3) State3 respiration with multiple
substrates (complex I- and II-related substrates) after
addition of pyruvate and glutamate (State3MULTI).
Due to lack of material or low respiratory activity,
Protocol 2 and State4 respiration in Protocol 1 before
training were not performed in eight (control n=5, type 2
diabetes n=3) and seven (control n=5, type 2 diabetes n=2)
participants, respectively.
Respiratory control index (RCI) (=State3 divided by
State4) and ratio of ADP consumed:oxygen utilised (i.e.
ADP added divided by oxygen consumption during State3)
were calculated when using pyruvate+malate and
palmitoyl-L-carnitine+malate, and used to evaluate the
success of the isolation procedure, and the integrity and
coupled state of inner mitochondrial membrane.
Mitochondrial ROS release Mitochondrial hydrogen per-
oxide (H2O2) release (nmol H2O2 min
−1 [U CS activity]−1)
was measured in isolated mitochondria with Amplex Red
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(Molecular Probes, Carlsbad, CA, USA) as a trapper of
H2O2, catalysed by horseradish peroxidase. Mitochondrial
superoxide (O2
−) is converted to H2O2 by addition of
superoxide dismutase. H2O2 reacts with Amplex Red in a
1:1 stoichiometry yielding the fluorescent compound
resorufin (excitation 560 nm, emission 590 nm), which is
stable once formed. Fluorescence was measured continuous-
ly with a spectrofluorometer equipped with temperature
control and magnetic stirring (Ratiomaster RCM; Photon
Technology, Brunswick, NJ, USA). Isolated mitochondria
were added to the measurement buffer containing (in mmol/l
unless otherwise stated): mannitol 225; sucrose 75; Tris 10;
KCl 10; K2HPO4 10; EDTA 0.1; MgCl2·(6H2O) 0.08;
Amplex Red 0.05; horseradish peroxidase 12 U/ml; oligo-
mycin 2 µg/ml; and superoxide dismutase 90 U/ml; pH 7.0.
Mitochondrial H2O2 release was determined after addition of
succinate (5.1 mmol/l) plus rotenone (2.1 µmol/l) for
measurement of mitochondrial ROS release in the presence
of rotenone (ROSrot), which describes ROS production from
complex III without blockage of forward electron flow. For
measurement of mitochondrial ROS release in the presence of
antimycin A (ROSanti), antimycin A (1.5 µg/ml) was added,
which blocked electron flow, causing maximal superoxide
production from complex III. Four different concentrations of
H2O2 were added to establish a standard curve.
Expression of genes encoding mitochondrial proteins and
markers of mitochondrial biogenesis Total RNA was
extracted from 1.0 to 2.5 mg freeze-dried muscle with a
reagent (PureZOL; Bio-Rad Laboratories, Sundbyberg,
Sweden). RNA purity and concentration were determined
with spectrometry. RNA (1 μg) was used for transcription
of 20 μl cDNA with a kit (iScript cDNA Synthesis; Bio-
Rad). Real-time PCR amplification mixtures (25 μl)
contained 12.5 μl 2×SYBR Green Supermix (Bio-Rad),
0.5 μl 10 μmol/l forward and reverse primers respectively,
and 11.5 μl template cDNA and RNase-free water together.
Control group and diabetes samples were run on the same
plate to permit direct relative comparisons. Real-time PCR
was performed with iCycler (Bio-Rad). A series of genes
were determined, which included CPT1B, PDK4, COX1
(also known as PTGS1), COX4 (also known as COX4I1),
PGC-1α (also known as PPARGC1A), PGC-1β (also
known as PPARGC1B), PPARA, PPAR-β (also known as
PPARD), PPARG, PRC (also known as PPRC1) and
GAPDH was used as reference gene. mRNA relative levels
were automatically analysed by the Normalised Expression
Vandesompele (ΔΔCT Advanced) tool in the software
(iCycler; Bio-Rad).
Fibre-type distribution, UCP3 protein content and CS
activity Fibre-type distribution was determined by electro-
phoresis as different isotypes of myosin heavy chain
(MHC) I, MHC II and MHC IIx as previously described
[32]. UCP3 was determined in fourteen participants (type 2
diabetes n=6, control n=8). Determination of UCP3 protein
content was analysed in duplicate as described in detail
previously [33]. The U CS activity in the mitochondrial rich
solutions (CSmito) and of CS per g muscle wet weight
(CSmuscle) was determined spectrophotometrically at 25°C
as described by Alp et al. [34]. Intrinsic mitochondrial
respiration and H2O2 production in isolated mitochondria
were determined by relating measures to CSmito. Respiration
per kg wet weight was calculated by multiplying intrinsic
respiration by CSmuscle activity.
Statistics Data are presented as means±SEM. A software
package (Systat software, Richmond, CA, USA) was used
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Fig. 1 Representative oxygraphic traces of mitochondrial oxygen con-
sumption in isolated mitochondria for Protocol 1 (a) and Protocol 2 (b).
Addition of substrates and isolated mitochondria (Mito) is indicated by
arrows above the trace. Different parts of the trace are indicated by arrows
below the trace. *Alamethicin and cytochrome c added in addition to
NADH. The increased oxygen content prior to addition of NADH is due
to aeration of the chamber in order to maintain adequate oxygen tension.
PC, palmitoyl-L-carnitine; P+G, pyruvate+glutamate; Succi, succinate
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for all statistical calculations. Differences between groups
pre- and post-training and the effect of training were
evaluated by two-way ANOVA with repeated measures.
Significant main effects or interactions were further
analysed by Bonferroni post hoc tests. Correlations were
examined by calculation of Pearson’s correlation coeffi-
cients. Significance was accepted at p≤0.05.
Results
Participant characteristics Patients with type 2 diabetes
and control participants were matched with respect to age,
BMI and V

O2peak (Table 1). Training caused a significant
increase in V

O2peak in both groups, with no difference in
increase between groups (type 2 diabetes 12±4% vs control
16±2%, p=0.4) (Table 1). Training also resulted in a
significant decrease in weight and BMI, but only in control
participants (Table 1).
Insulin sensitivity and blood profile Rd was significantly
lower in type 2 diabetes patients both before and after
training (Table 2). Training caused a significant increase in
Rd in type 2 diabetes (13%, p=0.001) and control
participants (22%, p<0.001). Before and after training,
type 2 diabetes patients had significantly higher HbA1c and
plasma glucose levels. Neither plasma glucose levels nor
HbA1c were significantly altered in response to training
(Table 2). Rd did not correlate with intrinsic mitochondrial
respiratory function or mitochondrial ROS release.
Respiration in isolated mitochondria When expressed per
kg muscle mass, training caused a significant ∼63% increase
in respiration with complex I-supported substrates (pyruvate
and glutamate) in both groups. Training also increased
ETCmax and mitochondrial lipid oxidation (palmitoyl-L-
carnitine+malate) in type 2 diabetes patients (Fig. 2a, b).
Similar changes were observed with other substrates, but the
changes were not statistically significant (Fig. 2b). There was
no difference between groups in the respiratory measures
(Fig. 2).
When expressed per mitochondrial density (i.e. CS
activity), training increased intrinsic State3PYRUVATE (p=
0.02) and State3PYRUVATE+GLUTAMATE (p=0.03), and de-
creased State4PALMITOYL-L-CARNITINE (p=0.005) and
State4PYRUVATE (p=0.01) in the whole groups of partic-
ipants (Table 3). When divided into groups, training tended
to increase State3PYRUVATE (p=0.07) and State3PYRUVATE+
GLUTAMATE (p=0.06) in control participants, but there were
otherwise no significant changes in intrinsic respiratory
Characteristics Pre-training Post-training
Type 2 diabetes Control Type 2 diabetes Control
n 13 14 12 12
Age (years) 52.3±1.3 52.6±1.6 52.5±1.4 52.8±1.7
Weight (kg) 108±2 109±3 108±2 108±4a
BMI (kg/m2) 33.5±1.0 32.9±0.7 33.4±1.0 32.6±0.8a
FFM (kg) 72.7±1.9 74.1±2.0 74.3±1.7 75.5±2.2
V

O2peak
(ml O2/min)
2,865±108 3,042±164 3,203±113a 3,688±193a
V

O2peak
(ml O2 min
−1 FFM−1)
39.5±1.4 41.8±2.3 43.2±1.5a 48.1±2.7a
Fibre type composition
MHC I 36.4±2.4 34.7±3.4 36.0±3.1 35.6±2.4
MHC II 56.8±2.8 59.2±3.4 57.0±2.7 61.4±2.6
MHC IIx 6.7±1.6 6.1±1.1 7.1±1.4 2.9±0.8
Table 1 Anthropometric and
physical fitness characteristics
Values are mean±SE
a p<0.05 vs pre-training
FFM, fat-free-mass
Variable Pre-training Post-training
Type 2 diabetes Control Type 2 diabetes Control
n 13 14 12 12
Diabetes duration (years) 3.7±0.8 – – –
Rd (mg min
−1 [kg FFM]−1) 6.5±0.8 10.3±0.7a 7.3±0.9b 12.5±1.2a,b
Fasting plasma glucose (mmol/l) 9.4±0.5 5.7±0.1a 9.2±0.5 5.5±0.1a
HbA1c (%) 7.2±0.3 5.2±0.1
a 7.0±0.3 5.3±0.1a
Table 2 Clinical data and blood
profile
Values are mean±SE
a p<0.05 vs type 2 diabetes;
b p<0.05 vs pre-training
FFM, fat-free-mass
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measures within groups (Table 3). Training caused a
significant increase in RCI pyruvate and RCI palmitoyl-L-
carnitine in the whole group of participants. Within groups,
type 2 diabetes patients also had a significant increase in RCI
palmitoyl-L-carnitine (Table 3).
Mitochondrial ROS release Pre-training type 2 diabetes
patients tended to have a higher succinate-supported
mitochondrial ROSrot (p=0.10), but there was no difference
after addition of antimycin A (ROSanti) (Fig. 3). Training
tended to decrease ROSrot in the whole group of partic-
ipants (p=0.10), but had no significant effect on ROSanti.
CS activity, UCP3 protein content and fibre-type composition
Training caused a significant increase in muscle CS activity in
both groups (type 2 diabetes pre 60.8±5.6, post 98.0±9.6;
control pre 78.5±4.3, post 102.4±9.1 U/mg dry weight; p<
0.01), but there was no difference between groups either
before or after training. Due to limited material, UCP3 protein
content was only determined in 14 participants (n=6 type 2
diabetes, n=8 control). In the whole group of participants,
UCP3 protein content increased ∼69% in response to training.
When divided into groups, only control participants showed a
significant increase in UCP3 protein content (control 71±
26%, p<0.001; type 2 diabetes 67±65%, p=0.4). There was
no significant difference between groups in fibre-type com-
position. Training caused a 60% decrease in MHCIIx in
control participants. However, this decrease was not statisti-
cally significant (Table 1, Fig. 4).
Gene expression Pre-training type 2 diabetes patients had
significantly higher expression of PDK4 than control
participants, but there were no other differences in gene
expression between groups. Training increased mRNA of
PPARG significantly in type 2 diabetes patients (p=0.02)
and in control participants (p=0.001) (Fig. 5b). Interest-
ingly, mRNA of PDK4 (p<0.001), COX1 (p=0.008) and
COX4 (p=0.02) increased significantly in control partic-
ipants after training (Fig. 5a), but not in type 2 diabetes
patients.
Discussion
The main result of the present study is that 10 weeks of
aerobic training resulted in a significant increase in
mitochondrial respiratory capacity when determined per
muscle weight. When respiration was related to a marker
of mitochondrial content (intrinsic), training resulted in
increased complex I-supported respiration and a decrease in
State4 respiration. Training also increased expression of
genes encoding mitochondrial ETC proteins and of PPARG,
suggesting increased mitochondrial biogenesis. There was
no difference in training adaptability between type 2
diabetes and control participants. This demonstrates that
aerobic training improves muscle oxidative function re-
gardless of the degree of insulin resistance. Another
interesting finding was that mitochondrial ROS release
tended to be higher in type 2 diabetes patients than in
control participants and tended to decrease in response to
training.
Effect of training on mitochondrial respiration and mito-
chondrial biogenesis The main purpose of the present
study was to investigate the effect of physical training on
several mitochondrial variables in obese participants with
and without type 2 diabetes, and matched for physical
fitness, obesity and age. Training resulted in a large (about
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Fig. 2 Respiration in isolated mitochondria. State3 respiration in isolated
mitochondria was calculated per kgwet weight of muscle for a pyruvate+
malate (PYR), pyruvate+malate+glutamate (P+G) and cytochrome c+
alamethicin+NADH (ETCmax), and b palmitoyl-L-carnitine+malate
(PC), palmitoyl-L-carnitine+malate+succinate (Succi) and palmitoyl-L-
carnitine+malate+succinate+pyruvate+glutamate (MULTI). Black bars,
type 2 diabetes participants pre-training; white bars, control participants
pre-training; dark grey bars, type 2 diabetes participants post-training;
light grey bars, control participants post-training. Data are mean±SEM.
*p<0.05 vs pre-training within group
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63%) increase in muscle oxidative capacity shown by
increased State3 respiration per kg muscle weight. These
results are in accordance with a recent study showing that
in vivo mitochondrial function increased in type 2 diabetic
and control participants [26]. The present study expands on
this finding by showing that the adaptation seems to be
most pronounced in the mitochondrial ability to use
complex I-supporting substrates, since the most significant
adaptation was when pyruvate and glutamate were used as
substrates (Fig. 2a). As suggested by Meex et al. [26], an
increase in muscle oxidative capacity is most likely to be
caused by increased mitochondrial content and/or increased
intrinsic mitochondrial activity. In the present study, CS
activity, a marker of mitochondrial content, increased by
∼50% in the whole group. Furthermore, even though
biopsies were taken 48 h after the last training session,
expression of genes encoding several mitochondrial pro-
teins was significantly increased, supporting a sustained
increase in mitochondrial biogenesis (Fig. 5a, b). Even
though the response to training in some cases seemed to be
more pronounced in control participants (expression of
PDK4, COX1 and COX4; MHCIIx protein levels), collec-
tively the results suggest that the higher degree of insulin
resistance in type 2 diabetes patients does not alter the
adaptation of muscle oxidative capacity and mitochondrial
functionality.
An interesting finding of this study was that intrinsic
mitochondrial respiration with NADH-generating sub-
strates (pyruvate and glutamate) increased about 11% in
response to training, whereas that with other substrate
combinations (ETCmax, State3PALMITOYL-L-CARNITINE,
State3PALMITOYL-L-CARNITINE+SUCCINATE, State3MULTI)
was unchanged. The increased State3PYRUVATE and
Variable Pre-training Post-training
Type 2 diabetes Control Type 2 diabetes Control
n 13 12 12 12
Pyruvate+malate
State3b 79.7±3.8 73.2±4.7 87.1±3.7 82.4±3.1
State4b,c,g 7.5±0.8 6.7±1.2 5.5±0.8 4.9±0.4
RCIb,c,g 11.8±1.4 9.9±0.9 14.3±1.4 13.9±0.6
P:O ratioe,g 2.75±0.04 2.61±0.08 2.58±0.03 2.62±0.02
Palmitoyl-L-carnitine+malate
State3f,g 47.8±2.1 51.0±1.7 51.6±3.0 46.3±2.5
State4b,f,g 7.4±0.8 6.6±0.40 5.3±0.3 5.1±0.3
RCIb,d,g 5.9±0.4 6.3±0.3 8.7±0.6b 7.7±0.3
P:O ratiod,g 2.47±0.04 2.49±0.03 2.42±0.03 2.49±0.04
State3G+P
b 76.4±4.5 66.7±6.0 84.9±4.4 81.2±2.9
State3PC+S
f,g 116±9 128±4 123±5 111±6
State3MULTI
f,g 129±12 140±7 145±6 136±7
ETCmax 260±16 243±26 245±28 224±14
Table 3 Mitochondrial
respiratory function
Values are mean±SE
a p<0.05 vs pre-training; b p<0.05
pre- vs post-training in the whole
group of participants
c n=11, d n=8, e n=12 and f n=10
type 2 diabetes in the pre-training
state; g n=9 controls in
pre-training state
ETCmax, alamethicin+
cytochrome c+NADH; P:O
ratio, ratio of ADP consumed:
oxygen utilised; State3G+P,
State3 glutamate+pyruvate+
malate; State3PC+S, State3
palmitoyl-L-carnitine+succinate;
State3MULTI, State3 pyruvate+
malate+glutamate+palmitoyl-
L-carnitine+succinate
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Fig. 3 Mitochondrial H2O2 release. Hydrogen peroxide (H2O2)
release in isolated mitochondria with succinate+rotenone+oligomycin
(ROSrot) and succinate+rotenone+oligomycin+antimycin A (ROSanti)
from skeletal muscle of obese control participants and obese patients
with type 2 diabetes. Black bars, type 2 diabetes participants pre-
training; white bars, control participants pre-training; dark grey bars,
type 2 diabetes participants post-training; light grey bars, control
participants post-training. Values were from 12 type 2 diabetes
patients and 12 (pre-training) and nine (post-training) control
participants. Data are mean±SEM
Fig. 4 Representative blot showing MHC from one participant per
group
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State3PYRUVATE+GLUTAMATE without any change in ETCmax
may be related to improved provision of NADH to ETC
from the tricarboxylic acid cycle or from the reactions
mediated by pyruvate dehydrogenase and glutamate dehy-
drogenase. An increase in State3 respiration in response to
increased training status is in contrast to what we [35] and
others [33] have reported previously in young, trained and
untrained participants. Values of State3PYRUVATE obtained
prior to training were about 15% lower in this study than
previously observed in young non-obese participants [35].
However, after training State3PYRUVATE increased to the
same level as in young participants. This difference
between young lean and middle-aged obese participants in
intrinsic mitochondrial respiration is in accordance with
previous reports [33] and is most likely to be due to
differences in physical fitness and/or age.
Mitochondrial ROS release and the effect of training Pre-
vious studies have suggested that increased cytosolic
concentration of free radicals have an inhibitory effect on
the insulin signalling cascade [16]. A main purpose of the
present study was to investigate the hypothesis that insulin
resistance is associated with increased mitochondrial ROS
release. We showed that type 2 diabetes patients tended to
have higher ROSrot, which training tended to decrease. A
recent study showed that type 2 diabetes patients had higher
mitochondrial ROS release than matched obese control
participants [19]. It has also been shown that type 2
diabetes patients had significantly higher ROS release than
lean participants when related to ATP production, but
similar ROS release when related to mitochondrial protein
[19]. Similarly to the protocol used by Abdul-Ghani et al.
[19], ROSrot was determined in the presence of rotenone,
which inhibits the unphysiological backflow of electrons
from complex II to complex I. The fate of the electrons is
therefore: (1) to be donated to oxygen, forming water in
complex IV; or (2) to be donated to oxygen, forming
superoxide in complex III. Although this in vitro model
may not correspond to conditions in vivo, the results
demonstrate an increased potential for ROS release in ETC,
which will probably have an impact on ROS production in
vivo. The excessive supply of substrate in type 2 diabetes
(hyperglycaemia and hyperlipidaemia) may be an additional
factor that increases ROS production in vivo.
One mitochondrial protein related to mitochondrial ROS
production is UCP3. Previous studies have suggested that
UCP3 acts as a protective mechanism against mitochondrial
ROS production [36]. Indeed, training did cause a signif-
icant 72% increase in UCP3 protein in the whole group of
participants. Moreover, as described above, it also caused a
∼50% increase in mitochondrial content (CS activity).
Thus, UCP3 protein levels per mitochondrion would also
have been increased and may in part explain the tendency
towards decreased intrinsic mitochondrial ROS release.
However, further research is needed to verify that UCP3
contributes to uncoupling, thereby leading to lower ROS
production in humans.
The potential link between insulin resistance and mitochon-
drial function During the last decade there has been an
increased interest in the potential link between mitochon-
drial function in skeletal muscle and insulin sensitivity in
obesity and type 2 diabetes. However, only few studies
have assessed intrinsic mitochondrial function. Of these,
some have shown lower intrinsic mitochondrial function
[6, 12, 13], whereas others have been unable to detect a
difference between type 2 diabetes patients and control
participants [9–11, 14, 15, 37]. One study, moreover,
showed higher lipid oxidation in isolated mitochondria in
patients with type 2 diabetes [38]. Recently, we reported
impaired mitochondrial respiration in skeletal muscle of
patients with type 2 diabetes when measured as ETCmax
and State3PYRUVATE respiration [13]. However, in that
study, the level of physical activity and aerobic capacity
was not determined. In the present study, groups had
similar aerobic capacities and there was no difference in
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Fig. 5 Training-induced changes in expression of genes encoding
markers of mitochondrial biogenesis and mitochondrial proteins,
shown as changes in mRNA of mitochondrial proteins (a) and of
proteins inducing mitochondrial biogenesis (b, c). Black bars, type 2
diabetes participants; white bars, control participants; horizontal lines,
pre-training values. Values are from eight type 2 diabetes patients and
eight control participants. Data are mean±SEM. *p<0.05 vs pre-
training within group
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any intrinsic respiratory measures. We have also demon-
strated that physical training increases intrinsic mitochon-
drial respiration. We therefore suspect that the difference in
intrinsic mitochondrial respiration reported in our previous
study was due to lower physical fitness in type 2 diabetes
patients than in the control participants.
In summary, the present study shows that aerobic
training increases muscle oxidative capacity and intrinsic
mitochondrial State3 respiration, decreases State4 respira-
tion and increases mitochondrial biogenesis in middle-aged
obese men with and without type 2 diabetes. Increased
State3 and decreased State4 respiration represent an
increase in mitochondrial functionality that is most likely
to be related to an improvement in mitochondrial substrate
handling. Type 2 diabetes patients were significantly more
insulin-resistant than control participants matched for age,
obesity and physical activity, but there were no differences
between groups in mitochondrial respiration. These findings
refute the hypothesis that the additional insulin resistance
seen in obese type 2 diabetic patients vs those with obesity
alone is caused by low intrinsic mitochondrial activity or low
oxidative capacity. However, the possibility that a combina-
tion of low muscle oxidative capacity and substrate overload
(hyperglycaemia, hyperlipidaemia) creates a condition of
increased ROS production and insulin resistance remains to
be investigated.
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